Bleichroeder Acquisition Corp. I Files S-1

TL;DR

Bleichroeder Acquisition Corp. I filed an S-1, signaling a potential public offering.

AI Summary

Bleichroeder Acquisition Corp. I filed an S-1 registration statement on July 12, 2024, to register securities. The company, incorporated in the Cayman Islands, is headquartered at 1345 Avenue of the Americas, New York, NY. Andrew Gundlach serves as the Chief Executive Officer.

Why It Matters

This S-1 filing indicates Bleichroeder Acquisition Corp. I is preparing to offer securities to the public, which could involve a future IPO or other capital raise.

Risk Assessment

Risk Level: medium — S-1 filings are standard for companies going public, but the specific details of the offering and the company's business plan will determine the ultimate risk.

Key Numbers

• 333-280777 — SEC File Number (Identifies this specific registration statement with the SEC.)
• 0002028707 — Central Index Key (Unique identifier for the company in the SEC's EDGAR system.)

Key Players & Entities

• Bleichroeder Acquisition Corp. I (company) — Registrant
• July 12, 2024 (date) — Filing Date
• Andrew Gundlach (person) — Chief Executive Officer
• 1345 Avenue of the Americas, New York, NY (location) — Principal Executive Offices
• Cayman Islands (location) — Jurisdiction of Incorporation

FAQ

Key Financial Figures

• $250,000,000 B — 0;DATED  JULY 12 , 2024 $250,000,000 Bleichroeder Acquisition Corp. I
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordi
• $11.50 — s A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $1.00 — hare at $11.50 per share, at a price of $1.00 per warrant, or $2,000,000 in the aggre
• $2,000,000 — re, at a price of $1.00 per warrant, or $2,000,000 in the aggregate (including if the unde
• $100,000 — (net of permitted withdrawals and up to $100,000 of interest income to pay dissolution e
• $0.10 — x00a0;    Includes $0.10 per unit (including any units sold purs
• $2,500,000 — ption to purchase additional units), or $2,500,000 in the aggregate (or up to $2,875,000 i
• $2,875,000 — r $2,500,000 in the aggregate (or up to $2,875,000 in the aggregate if the underwriter&#x2
• $1,250,000 — al units is exercised). Of this amount, $1,250,000 shall be payable to Santander US Capita
• $1,625,000 — this offering and $1,250,000 (or up to $1,625,000 in the event to underwriter’s ov
• $0.475 — ial business combination. Also includes $0.475 per unit on all units sold ($11,875,000
• $11,875,000 — udes $0.475 per unit on all units sold ($11,875,000 in the aggregate or up to $13,656,250 i
• $13,656,250 — ($11,875,000 in the aggregate or up to $13,656,250 in the aggregate if the underwriter&#x2
• $250.0 — warrants described in this prospectus, $250.0 million, or $287.5 millio

Filing Documents

• ea0209024-01.htm (S-1) — 3706KB
• ea020902401ex3-1i_bleich.htm (EX-3.1(I)) — 29KB
• ea020902401ex3-1ii_bleich.htm (EX-3.1(II)) — 633KB
• ea020902401ex4-1_bleich.htm (EX-4.1) — 19KB
• ea020902401ex4-2_bleich.htm (EX-4.2) — 20KB
• ea020902401ex4-4_bleich.htm (EX-4.4) — 152KB
• ea020902401ex5-1_bleich.htm (EX-5.1) — 11KB
• ea020902401ex5-2_bleich.htm (EX-5.2) — 58KB
• ea020902401ex10-1_bleich.htm (EX-10.1) — 47KB
• ea020902401ex10-2_bleich.htm (EX-10.2) — 94KB
• ea020902401ex10-3_bleich.htm (EX-10.3) — 121KB
• ea020902401ex10-4_bleich.htm (EX-10.4) — 40KB
• ea020902401ex10-5_bleich.htm (EX-10.5) — 101KB
• ea020902401ex10-6_bleich.htm (EX-10.6) — 25KB
• ea020902401ex10-7_bleich.htm (EX-10.7) — 65KB
• ea020902401ex14-1_bleich.htm (EX-14.1) — 55KB
• ea020902401ex23-1_bleich.htm (EX-23.1) — 2KB
• ea020902401ex99-1_bleich.htm (EX-99.1) — 43KB
• ea020902401ex99-2_bleich.htm (EX-99.2) — 33KB
• ea020902401ex99-3_bleich.htm (EX-99.3) — 3KB
• ea020902401ex99-4_bleich.htm (EX-99.4) — 3KB
• ea020902401ex99-5_bleich.htm (EX-99.5) — 3KB
• ea020902401ex-fee_bleich.htm (EX-FILING FEES) — 41KB
• ex3-1i_001.jpg (GRAPHIC) — 4KB
• ex3-1i_002.jpg (GRAPHIC) — 2KB
• ex3-1i_003.jpg (GRAPHIC) — 2KB
• ex3-1ii_001.jpg (GRAPHIC) — 10KB
• ex3-1ii_002.jpg (GRAPHIC) — 12KB
• ex3-1ii_003.jpg (GRAPHIC) — 2KB
• ex5-2_001.jpg (GRAPHIC) — 2KB
• 0001213900-24-061026.txt ( ) — 5352KB

Risk Factors

Risk Factors   36 Cautionary Note Regarding Forward-Looking Statements   81

Use of Proceeds

Use of Proceeds   82 Dividend Policy   85

Dilution

Dilution   86 Capitalization   89 Management’s Discussion and Analysis of Financial Condition and Results of Operations   90 Proposed Business   96 Effecting our Initial Business Combination   107 Management   126 Principal Shareholders   135 Certain Relationships and Related Party Transactions   138

Description of Securities

Description of Securities   141 Taxation   162

Underwriting

Underwriting   176 Legal Matters   184 Experts   184 Where You Can Find Additional Information   184 Index to Financial Statements   F-1 We are responsible for the information contained in this prospectus. We have not, and the underwriter has not, authorized anyone to provide you with information that is different from or inconsistent with that contained in this prospectus. We are not, and the underwriter is not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under “Risk Factors” and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus or the context otherwise requires, references to: •       &#

View Full Filing

View this S-1 filing on SEC EDGAR